Cantitate/Preț
Produs

Biomarkers for Alzheimer’s Disease Drug Development: Methods in Molecular Biology, cartea 2785

Editat de Robert Perneczky
en Limba Engleză Hardback – 2 mar 2024
This fully updated volume provides an up-to-date and comprehensive overview of the current state of technologies helping to accelerate Alzheimer’s disease drug development. Addressing the latest advances in preclinical and clinical research, including new insights into the molecular mechanisms and emerging therapeutic strategies, the book continues by exploring digital biomarkers and advanced neuroimaging analysis which will transform how clinical trials in the Alzheimer’s disease field are performed. Written for the highly successful Methods in Molecular Biology series, chapters feature the kind of detailed implementation advice that leads to greater success in the lab or clinic. 

Authoritative and practical, Biomarkers for Alzheimer’s Disease Drug Development, Second Edition seeks to inspire and inform future efforts to develop effective treatments for this devastating disease.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 54394 lei  39-44 zile
  Springer – 14 aug 2020 54394 lei  39-44 zile
Hardback (2) 78458 lei  6-8 săpt.
  Springer – 7 mar 2018 78458 lei  6-8 săpt.
  Springer Us – 2 mar 2024 110992 lei  39-44 zile

Din seria Methods in Molecular Biology

Preț: 110992 lei

Preț vechi: 116834 lei
-5% Nou

Puncte Express: 1665

Preț estimativ în valută:
21251 22129$ 17632£

Carte tipărită la comandă

Livrare economică 10-15 februarie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781071637739
ISBN-10: 1071637738
Pagini: 347
Ilustrații: XII, 347 p. 51 illus., 49 illus. in color.
Dimensiuni: 178 x 254 mm
Greutate: 0.84 kg
Ediția:2nd ed. 2024
Editura: Springer Us
Colecția Humana
Seria Methods in Molecular Biology

Locul publicării:New York, NY, United States

Cuprins

Blood-Based Biomarkers for Early Alzheimer’s Disease Diagnosis in Real-World Settings.- Alzheimer’s Disease Prevention and Treatment Based on Population-Based Approaches.- CSF N-Glycomics Using High Throughput UPLC-ESI Techniques in Alzheimer’s Disease.- CSF N-Glycomics Using MALDI MS Techniques.- Optimized Pre-Analytical Handling Protocol for Blood-Based Biomarkers of Alzheimer’s Disease.- Mass Spectrometry-Based Metabolomics Multi-Platform for Alzheimer’s Disease Research.- Analysis of Resting-State Functional Magnetic Resonance Imaging in Alzheimer's Disease.- Diffusion Tensor Imaging in Alzheimer’s Studies.- Magnetic Resonance Spectroscopy (MRS) in Alzheimer’s Disease.- Neuroimaging Methods for MRI Analysis in CSF Biomarkers Studies.- Amyloid PET Imaging: Standard Procedures and Semiquantification.- PET Imaging to Measure Neuroinflammation In Vivo.- Imaging Neuroinflammation: Quantification of Astrocytosis in a Multitracer PET Approach.- High-Throughput Lipidomics and Metabolomics Profiling for Brain Tissue and Biofluid Samples in Neurodegenerative Disorders.- Neuropathological Assessment as an Endpoint in Clinical Trial Design.- Non-Invasive Visualization of Amyloid-Beta Deposits in Alzheimer’s Amyloidosis Mice via Fluorescence Molecular Tomography Using Contrast Agent.- Brain Banking in Dementia Studies.- Speech-Based Digital Biomarkers for Alzheimer’s Research.- cCOG Web-Based Cognitive Assessment Tool.- In Silico Models to Validate Novel Blood-Based Biomarkers.

Textul de pe ultima copertă

This fully updated volume provides an up-to-date and comprehensive overview of the current state of technologies helping to accelerate Alzheimer’s disease drug development. Addressing the latest advances in preclinical and clinical research, including new insights into the molecular mechanisms and emerging therapeutic strategies, the book continues by exploring digital biomarkers and advanced neuroimaging analysis which will transform how clinical trials in the Alzheimer’s disease field are performed. Written for the highly successful Methods in Molecular Biology series, chapters feature the kind of detailed implementation advice that leads to greater success in the lab or clinic. 

Authoritative and practical, Biomarkers for Alzheimer’s Disease Drug Development, Second Edition seeks to inspire and inform future efforts to develop effective treatments for this devastating disease.

Caracteristici

Includes cutting-edge techniques Provides step-by-step detail essential for reproducible results Contains key implementation advice from the experts